mAbVista Overview

  • Founded
  • 2011


  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

mAbVista General Information


Operator of a biotechnology firm designed to specialize in the production of high quality monoclonal antibodies. The company's products provides highly specific, sensitive and versatile microscopy-qualified monoclonal antibodies for the acceleration and advancement of proteomics, enabling researchers to perform quantitative single cell analysis and high content drug screening.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Two Greenway Plaza
  • Suite 910
  • Houston, TX 77046
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

mAbVista Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Sep-2019 Completed Out of Business
1. Early Stage VC Completed Generating Revenue
To view mAbVista’s complete valuation and funding history, request access »